Skip to main content
Journal cover image

Worsening versus advanced heart failure: Management and challenges.

Publication ,  Journal Article
Palazzuoli, A; Del Buono, MG; La Vecchia, G; Greene, SJ; Ambrosy, AP; Chioncel, O; Gustafsson, F; Krim, SR; Lavie, CJ; Adamo, M; Gal, TB ...
Published in: ESC Heart Fail
December 2025

Heart failure (HF) is a progressive condition marked by recurrent episodes of symptom exacerbation, leading to worsening cardiac function, increased hospitalization and mortality risk. Worsening HF (WHF) and advanced HF (AdvHF) represent two distinct stages in this progression, each with unique clinical features and therapeutic needs. WHF is characterized by a deterioration of pre-existing symptoms requiring intensified treatment, such as diuretic escalation, which often reflects disease progression. Conversely, AdvHF involves severe cardiac dysfunction with persistent symptoms despite optimal medical management, requiring advanced interventions such as inotropic support or heart transplant. Although both stages share some pathophysiological and clinical features, they differ significantly in haemodynamic profiles, disease severity and response to treatment. This review argues that recognizing the transition from WHF to AdvHF is a pivotal issue in patient care. We explore the distinct natural histories, clinical presentations and diagnostic markers of WHF and AdvHF to provide a framework for earlier, more targeted interventions aimed at altering the disease trajectory and preventing the decline associated with the advanced stage. While WHF symptoms are typically reversible with appropriate interventions, AdvHF represents the end stage of HF with often irreversible dysfunction and multi-organ involvement. A clearer understanding and standardized definition of these phenotypes are essential for improving patient outcomes and guiding future clinical research.

Duke Scholars

Published In

ESC Heart Fail

DOI

EISSN

2055-5822

Publication Date

December 2025

Volume

12

Issue

6

Start / End Page

3856 / 3868

Location

England

Related Subject Headings

  • Severity of Illness Index
  • Humans
  • Heart Failure
  • Disease Progression
  • Disease Management
  • 3201 Cardiovascular medicine and haematology
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Palazzuoli, A., Del Buono, M. G., La Vecchia, G., Greene, S. J., Ambrosy, A. P., Chioncel, O., … Crea, F. (2025). Worsening versus advanced heart failure: Management and challenges. ESC Heart Fail, 12(6), 3856–3868. https://doi.org/10.1002/ehf2.15437
Palazzuoli, Alberto, Marco Giuseppe Del Buono, Giulia La Vecchia, Stephen J. Greene, Andrew P. Ambrosy, Ovidiu Chioncel, Finn Gustafsson, et al. “Worsening versus advanced heart failure: Management and challenges.ESC Heart Fail 12, no. 6 (December 2025): 3856–68. https://doi.org/10.1002/ehf2.15437.
Palazzuoli A, Del Buono MG, La Vecchia G, Greene SJ, Ambrosy AP, Chioncel O, et al. Worsening versus advanced heart failure: Management and challenges. ESC Heart Fail. 2025 Dec;12(6):3856–68.
Palazzuoli, Alberto, et al. “Worsening versus advanced heart failure: Management and challenges.ESC Heart Fail, vol. 12, no. 6, Dec. 2025, pp. 3856–68. Pubmed, doi:10.1002/ehf2.15437.
Palazzuoli A, Del Buono MG, La Vecchia G, Greene SJ, Ambrosy AP, Chioncel O, Gustafsson F, Krim SR, Lavie CJ, Adamo M, Gal TB, Geavlete O, Antohi L, Rosano G, Collins S, Crea F. Worsening versus advanced heart failure: Management and challenges. ESC Heart Fail. 2025 Dec;12(6):3856–3868.
Journal cover image

Published In

ESC Heart Fail

DOI

EISSN

2055-5822

Publication Date

December 2025

Volume

12

Issue

6

Start / End Page

3856 / 3868

Location

England

Related Subject Headings

  • Severity of Illness Index
  • Humans
  • Heart Failure
  • Disease Progression
  • Disease Management
  • 3201 Cardiovascular medicine and haematology
  • 1102 Cardiorespiratory Medicine and Haematology